Search

Don Z Zhang

from Belle Mead, NJ
Age ~62
Get Report
Related to:
Alicia F Zhou, 27Janis M Ryan, 72Yisong S Chen, 63Wen Zhou, 37Benyuan Zhou, 68Zheng Jiang, 59Jerry ZhangYan C Zhou, 58Xiaodong Z Zhang, 63Wenhua Zhou, 61
Connected to:
Aaron N Zhang, 60Adelaide X Zhang, 48Aiai Zhang, 38Aijun Zhang, 70Airong Zhang, 72Alfred Zhang, 31Anderson Zhang, 34Angeline Zhang, 36Anli Zhang, 68Anming Zhang, 64

Don Zhang Phones & Addresses

  • 11 Koren Ln, Belle Mead, NJ 08502 (908) 874-0702

Resumes

Resumes

Don Zhang Photo 1

Technology Consulting Manager

View page
Location:
Belle Mead, NJ
Industry:
Pharmaceuticals
Work:
Accenture
Technology Consulting Manager
Bristol-Myers Squibb Jun 2003 - Aug 2008
Team Lead Manager
Bristol-Myers Squibb Jan 2000 - May 2004
Senior Business Analyst
Education:
Stevens Institute of Technology 2001 - 2004
Master of Science, Masters, Management Columbia University In the City of New York 1999 - 2001
University of Maryland Baltimore County 1993 - 1995
Masters, Biochemistry
Skills:
Business Analysis
Requirements Analysis
Vendor Management
Pharmaceutical Industry
Project Management
Project Portfolio Management
Validation
Process Improvement
Gmp
Sdlc
Software Project Management
Pmp
Integration
It Strategy
Quality Assurance
Sop
Lifesciences
21 Cfr Part 11
Veeva Vault
Business Intelligence
Business Process
Agile Methodologies
Enterprise Architecture
Change Management
Data Analysis
Data Warehousing
Postgresql
Visio
Cross Functional Team Leadership
Database Design and Modelling
Veeva Crm
Veeva Network
Certified Salesforce.com Developer
Salesforce.com
Software As A Service
Paas
Master Data Management
Data Governance
Capability Maturity Model Integration
Pharmaceutical Sales
Pharmacovigilance
Pharmaceutical Research
Pharmaceutical Manufacturing
Regulatory Affairs
Medical Affairs
Qaqc
Certifications:
Salesforce.com Force.com Developer
Pmp Certification
Don Zhang Photo 2

Don Zhang

View page
Don Zhang Photo 3

Don Zhang

View page
Don Zhang Photo 4

Don Zhang

View page
Don Zhang Photo 5

Student At University Of Nebraska-Lincoln

View page
Location:
United States
Industry:
Semiconductors

Publications

Us Patents

2H-Indazole Derivatives As Cdk4 And Cdk6 Inhibitors And Therapeutic Uses Thereof

View page
US Patent:
20210139459, May 13, 2021
Filed:
Jan 29, 2019
Appl. No.:
16/965376
Inventors:
- Wilmington DE, US
Michael John Costanzo - Warminster PA, US
Jirong Peng - Mequon WI, US
Don Zhang - Princeton NJ, US
International Classification:
C07D 401/14
A61K 45/06
Abstract:
2-Aminopyrimidine-substituted 2H-indazole compounds of formula (I), where Ris hydrogen, and their prodrugs, where Ris a metabolizable group under physiological conditions, as cyclin-dependent kinase (CDK) and cell-proliferation inhibitors, and therapeutic uses and methods of preparation thereof, are disclosed. These compounds, and pharmaceutically acceptable salts, solvates, prodrugs, and pharmaceutical compositions thereof, are useful for treating diseases and disorders associated with activity of cyclin-dependent kinases, in particular CDK4/6, including but not limited to various cancers and inflammation-related diseases or conditions.

2-Anilinopyrimidine Derivatives As Therapeutic Agents For Treatment Of Brain Cancers

View page
US Patent:
20190365755, Dec 5, 2019
Filed:
May 11, 2017
Appl. No.:
16/300949
Inventors:
- Wilmington DE, US
Michael John Costanzo - Warminster PA, US
Michael Alan Green - Easton PA, US
Jirong Peng - Mequon WI, US
Victoria Lynn Wilde - Montclair NJ, US
Don Zhang - Princeton NJ, US
Assignee:
Beta Pharma, Inc. - Wilmington DE
International Classification:
A61K 31/506
A61P 35/04
Abstract:
Methods of using substituted 2-anilinopyrimidine derivatives, and pharmaceutically acceptable salts, solvates, or compositions, for the treatment of brain cancers, in particular EGFR-mediated metastatic brain cancer, are disclosed.

Pharmaceutical Salts N-(2-(2-(Dimethylamino)Ethoxy)-4-Methoxy-5-((4-(1-Methyl-1H-Indol-3-Yl)Pyrimidin-2-Yl)Amino)Phenyl)Acrylamide And Crystalline Forms Thereof

View page
US Patent:
20190233399, Aug 1, 2019
Filed:
Jun 16, 2017
Appl. No.:
16/310239
Inventors:
- Wilmington DE, US
Michael J. Costanzo - Warminster PA, US
Michael A. Green - Easton PA, US
Jirong Peng - Mequon WI, US
Victoria Lynn Wilde - Montclair NJ, US
Don Zhang - Princeton NJ, US
Assignee:
Beta Pharma, Inc. - Wilmington DE
International Classification:
C07D 403/04
C07C 309/30
C07C 309/04
A61K 45/06
A61K 31/506
A61P 35/00
A61P 35/04
Abstract:
Crystalline forms of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide (1) and its pharmaceutically acceptable salts and compositions thereof useful for the treatment or prevention of diseases or medical conditions mediated through mutated forms of epidermal growth factor receptor (EGFR), such as various cancers, are disclosed.

2-H-Indazole Derivatives As Cyclin-Dependent Kinase (Cdk) Inhibotors And Therapeutic Uses Thereof

View page
US Patent:
20180148431, May 31, 2018
Filed:
Jan 29, 2018
Appl. No.:
15/882620
Inventors:
- Wilmington DE, US
Michael John Costanzo - Warminster PA, US
Jirong Peng - Mequon WI, US
Victoria Lynn Wilde - Montclair NJ, US
Don Zhang - Princeton NJ, US
Assignee:
Beta Pharma, Inc. - Wilmington DE
International Classification:
C07D 401/14
A61K 45/06
A61K 31/506
Abstract:
Indazole compounds of formula (I) as cyclin-dependent kinase (CDK) and cell-proliferation inhibitors, and therapeutic uses and methods of preparation thereof, are disclosed. These compounds, and pharmaceutically acceptable salts, solvates, prodrugs, and pharmaceutical compositions thereof, are useful for treating diseases and disorders associated with activity of cyclin-dependent kinases, in particular CDK4/6, including but not limited to various cancers and inflammation-related diseases or conditions.

2-H-Indazole Derivatives As Cyclin-Dependent Kinase (Cdk) Inhibitors And Therapeutic Uses Thereof

View page
US Patent:
20170210726, Jul 27, 2017
Filed:
Jul 24, 2015
Appl. No.:
15/328813
Inventors:
- Wilmington DE, US
Michael John Costanzo - Warminster PA, US
Jirong Peng - Mequon WI, US
Victoria Lynn Wilde - Montclair NJ, US
Don Zhang - Plainsboro NJ, US
Assignee:
Beta Pharma, Inc. - Wilmington DE
International Classification:
C07D 401/14
A61K 45/06
A61K 31/506
Abstract:
Indazole compounds of formula (I) as cyclin-dependent kinase (CDK) and cellproliferation inhibitors, and therapeutic uses and methods of preparation thereof, are disclosed. These compounds, and pharmaceutically acceptable salts, solvates, prodrugs, and pharmaceutical compositions thereof, are useful for treating diseases and disorders associated with activity of cyclin-dependent kinases, in particular CDK4/6, including but not limited to various cancers and inflammation-related diseases or conditions:

Aspiration And Biopsy Needle Apparatus And Devices And Applications Thereof

View page
US Patent:
20150305724, Oct 29, 2015
Filed:
Apr 23, 2015
Appl. No.:
14/694896
Inventors:
- Princeton NJ, US
Don Zhang - Plainsboro NJ, US
Assignee:
BETA PHARMA, INC. - Princeton NJ
International Classification:
A61B 10/02
Abstract:
This application discloses aspiration/biopsy needle apparatus, devices containing these needle apparatus, and methods using these needle apparatus and devices for aspiration or biopsy of samples, in particular biological samples from mammalian subjects. The novel aspiration/biopsy needle systems can find wide applications in the manufacture of fine needle aspiration (FNA)/biopsy devices for convenient cell harvesting and tissue sampling and analysis.
Control profile
Don Z Zhang from Belle Mead, NJ, age ~62 Get Report